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Abstract Objective: To determine the ability of bladder wall thickness (BWT) in
combination with non-invasive variables to distinguish patients with bladder outlet
obstruction (BOO).
Patients and methods: Patients completed the International Prostate Symptom
Score (IPSS) questionnaire and prostate size was measured by transrectal ultra-
sonography (US). Pressure-flow studies were performed to determine the urody-
namic diagnosis. BWT was measured at 250-mL bladder filling using
transabdominal US. Recursive partition analysis (RPA) recursively partitions data
for relating independent variable(s) to a dependent variable creating a tree of parti-
tions. It finds a set of cuts of the dependent variable(s) that best predict the indepen-
dent variable, by searching all possible cuts until the desired fit is reached. RPA was
used to test the ability of the combined data of BWT, maximum urinary flow rate
(Qmax), post-void residual urine volume (PVR), IPSS, and prostate size to predict
BOO.
Results: In all, 72 patients were included in the final analysis. The median BWT,
voided volumes, PVR, mean Qmax, and IPSS were significantly higher in patients
who had an Abrams/Griffiths (A/G) number of >40 (55 patients) compared to those
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MCC, maximum
cystometric capacity;
NPV, negative predic-
tive value;
PPV, positive predic-
tive value;
Pves, vesical pressure;
PVR, post-void resi-
dual urine volume;
Qmax, maximum urin-
ary flow rate
with an A/G number of 40 (17 patients). RPA revealed that the combination of
BWT and Qmax gave a correct classification in 61 of the 72 patients (85%), with
92% sensitivity and 65% specificity, 87% positive predictive value, and 76% nega-
tive predictive value (NPV) for BOO (area under the curve 0.85). The positive diag-
nostic likelihood ratio of this reclassification fit was 2.6.
Conclusions: It was possible to combine BWT with Qmax to create a new algo-
rithm that could be used as a screening tool for BOO in men with lower urinary tract
symptoms.
 2017 Production and hosting by Elsevier B.V. on behalf of Arab Association of
Urology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
LUTS are highly prevalent in the male population and it
was reported that 62.5% of men aged 40 years have
at least one LUTS in a study of five European countries
[1]. A pressure-flow study is the standard urodynamic
test for the diagnosis of BOO. However, pressure-flow
studies are invasive, expensive, and time consuming.
They can also cause discomfort, UTI, and haematuria
[2]. The maximum urinary flow rate (Qmax) measured
by uroflowmetry, is a poor diagnostic method for
BOO [3]. Also, although the post-void residual urine
volume (PVR) is increased in patients with BOO [4],
an important disadvantage of both uroflowmetry and
PVR measurement is that they cannot distinguish
between BOO and detrusor underactivity [5].
Ultra-structural morphological changes in the blad-
der wall have been studied by Elbadawi et al. [6] in a
number of specimens obtained from patients with
BOO. The main finding of that study was an increased
smooth muscle bulk, with or without interstitial collagen
deposition. Therefore, it has been assumed that the mea-
surement of this increase in bladder wall thickness
(BWT) might be an indicator for the presence of BOO.
Oelke et al. [7] found that the detrusor wall thickness
(DWT) decreases with increase in bladder filling until
a level of 250 mL is reached, then the decrease is not sta-
tistically significant.
The aim of the present study was to investigate the
diagnostic value of BWT in combination with other
non-invasive variables for BOO in men with LUTS.
For this purpose, recursive partition analysis (RPA), a
non-parametric method [8], recursively partitions data
for relating dependent variable(s) to an independent
variable creating a tree of partitions. The dependent
variables investigated in the present study were BWT,
Qmax, PVR, IPSS, and prostate size. The independent
variable was the urodynamics diagnosis, i.e. BOO.
RPA finds a set of cuts of the dependent variable(s) that
best predict the independent variable, by searching all
possible cuts until the desired fit is reached. Therefore,
in the present study we used RPA to test the ability of
the combined data of BWT, Qmax, PVR, IPSS, and pros-
tate size to predict BOO in men with LUTS.
Patients and methods
In all, 98 men with LUTS were consecutively included in
the study at three centres: The Radboud University MC,
Nijmegen, The Netherlands; Sohag University Hospital,
Sohag, Egypt; and Minia University Hospital, Minia,
Egypt. Ethical approvals were obtained from the local
ethics committees at the three centres, and all patients
signed a written consent and completed the IPSS ques-
tionnaire. Inclusion criteria were adult men with LUTS.
Exclusion criteria were patients with neurogenic blad-
der, history of previous prostatic surgery, or prostatic
carcinoma.
Patients were asked to stop using any medication for
their urological disorders for 3 days before the date of
investigation. TRUS was performed to measure the
prostate size. Dipstick urine analysis was performed to
exclude UTIs.
All patients underwent a pressure-flow study (Solar,
Medical Measurement Systems, Enschede, The
Netherlands, Laborie Delphis KT, Toronto, Canada).
A gas- or water-filled urethral catheter (6 F) and a rectal
catheter were inserted to monitor vesical pressure and
abdominal pressure, respectively. Water was infused at
room temperature at 50 mL/min until the maximum
cystometric capacity (MCC) was reached.
The BWT was measured during filling at 250 mL of
bladder volume or at the MCC for patients with small
bladder capacities. The bladder wall consists of bladder
adventitia, which has a bright appearance on US; the
detrusor muscle layer, which has a dark appearance on
US; and the innermost layer is the bladder mucosa,
which has a bright appearance on US [9,10]. Therefore,
the inner and outer bright lines were included in the
measurement of the BWT. A curvilinear 5-MHz US
transducer was positioned on the suprapubic area; the
BWT measurements were made on the sharpest image
obtained. Then, filling cystometry was continued until
the MCC was reached. Then, the patients were asked
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to void in the flowmeter in a sitting or standing position
according to their preference.
Statistical analysis was done with JMP 7.0.2 (SAS
Institute, Cary, NC, USA). The Mann–Whitney U-test
and Student’s t-test were used to measure differences
between groups. Spearman’s rank correlation was used
to test the strength of correlation between the BWT
and each of the urodynamic and non-urodynamic vari-
ables of the study. For the RPA [8], BWT, Qmax,
PVR, IPSS, and prostate size were the independent vari-
ables that were tested to best predict the dependent vari-
able (urodynamic diagnosis), i.e. BOO.
Results
In all, 98 patients planned for urodynamic assessment
were included in the study. Patients who voided
<100 mL were excluded [11], leaving 72 patients in
the final analysis. Five patients had a MCC of
<250 mL, the BWT was measured at the MCC and
re-calculated at 250 mL using the following equation
[12]: DWT1  R1 = DWT2  R2. The radius (R) of
the bladder was obtained from the bladder volume as
4p/3  R3.
Patients were categorised according to the Abrams/
Griffiths (AG) number into two groups: Group 1
included patients with an AG number of >40 (i.e.
BOO), while Group 2 included patients with an AG
number of 40 (i.e. no BOO). Table 1 shows the demo-
graphic and urodynamic characteristics of the two
groups.
Spearman’s rank correlation revealed a statistically
significant, weak-to-moderate correlation between
BWT and each of the following variables: Age
(q= 0.44; P< 0.001), IPSS (q= 0.31; P= 0.007),
and voided volumes (q= 0.45; P< 0.001). Fig. 1 shows
a box plot of the study variables.
In all, 23 of the 72 patients had detrusor overactivity
(DO) and 18 of them had BOO. The median BWT was
higher in patients without DO (49 patients) than in
patients with DO (23), at 4.1 vs 3.4 mm (P= 0.13).
In Group 1, the median BWT was higher in patients
with DO (18 patients) than in patients without DO
(37), at 4.5 vs 3.5 mm (P= 0.07). None of the above-
mentioned differences were statistically significantly
different.
RPA of these variables showed that the combination
of BWT and Qmax gave a correct classification in 61 of
the 72 patients (85%), with 92% sensitivity and 65%
specificity, 87% positive predictive value (PPV), and
76% negative predictive value (NPV) for BOO (area
under the curve 0.85). The positive diagnostic likelihood
ratio (LR) of this reclassification fit was 2.6.
Fig. 2 shows the classification responses of this non-
invasive combination; the computed probability of hav-
ing the diagnosis ‘obstructed’ was 96% using a Qmax
threshold of <7 mL/s in 32 of 72 patients. For patients
with a Qmax of >7 mL/s, the BWT was checked; a
threshold value of 2.7 mm had a 73% probability to
be ‘obstructed’ in 22 of 72 patients, the program then
exhaustively checked further various thresholds of Qmax,
the computed probability of having the diagnosis ‘ob-
structed’ was 84% using the Qmax threshold of
<11 mL/s in 17 of 72 patients.
Discussion
In the present study, a spectrum of urodynamic, and
non-urodynamic, non-invasive, variables were investi-
gated for their ability to distinguish patients with BOO.
Table 1 Comparison of demographic and urodynamic vari-
ables between groups.
Variable Group 1:
BOO
Group 2:
No BOO
P*
Number of patients 55 17
Age, years, mean (SD) 62.3 (6.6) 65.1 (12.3) 0.2
IPSS, mean (SD) 21.2 (5.1) 17.2 (5.6) 0.01
Prostate size, mL, median
(range)
59 (23–130) 50 (21–296) 0.2
MCC, mL, mean (SD) 363 (94.5) 351.3 (95.7) 0.6
Voided volume, mL,
median (range)
200 (100–652) 266 (129–467) 0.01
Qmax, mL/s, mean (SD) 6.4 (2.5) 9.7 (2.8) <0.001
PVR, mL, median (range) 145 (4–420) 39 (0–200) 0.001
Pdet at Qmax, cmH2O,
median (range)
89 (52–165) 510 (24–66) <0.001
A/G number, mean (SD) 77.8 (25.3) 28.4 (7.9) <0.001
BWT, mm, median (range) 4 (1.9–5.8) 2.8 (1.6–5.2) 0.02
Pdet.at Qmax, detrusor pressure at Qmax.
* Mann-Whitney U-test or Student’s t-test with significance level
at P< 0.05.
Fig. 1 Box-plots of study variables: (A) IPSS; (B) Prostate size; (C) Qmax; (D) PVR; (E) BWT.
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BWT has been assumed to represent the hypertrophic
effect of BOO on the bladder wall. Hakenberg et al. [13]
reported that a mean (SD) BWT of 3.6 (0.1) mm in a
group of men aged >60 years with LUTS/BPH was sig-
nificantly higher than the other two healthy groups in
their study, at a mean (SD) of 3.33 (0.08) mm for
healthy men and 3.05 (0.06) mm for healthy women
(P< 0.002).
Previous studies have reported that BWT indepen-
dently distinguish patients with BOO [14,15]. This find-
ing was reproducible in the present study, the median
BWT was significantly higher in the group of patients
Qmax < 7
Level Rate Probability Count
BOO 0.96 0.96 31
NO 
BOO
0.04 0.04 1
BWT < 2.7 mm
Level Rate Probability Count
BOO 0.20 0.20 2
NO 
BOO
0.80 0.80 8
BWT ≥ 2.7 mm
Level Rate Probability Count
BOO 0.73 0.73 22
NO 
BOO
0.27 0.27 8
Qmax < 11 mL/s
Level Rate Probability Count
BOO 0.85 0.85 17
No BOO 0.15 0.15 3
Qmax ≥ 11 mL/s
Level Rate Probability Count
BOO 0.50 0.50 5
No BOO 0.50 0.50 5
All variables
Count = 72 paents
Level Rate Probability Count
BOO 0.76 0.76 55
No BOO 0.24 0.24 17
max < 7 mL/s
Level Rate Probability Count
B O 0.96 0.96 31
No BOO .04 .04 1
Qmax ≥ 7 mL/s
Level Rate Probability Count
BOO 0.60 0.60 24
No BOO 0.40 0.40 16
BWT < 2.7 m
Lev l Rate Probability Count
BOO 0.20 0.20 2
No BOO 0.80 0.80 8
B T ≥ 2.7 
Level Rate r ilit t
BOO 0.73 .
No BOO 0.27 .
Fig. 2 Classification response of RPA. The RPA program found no suitable cuts in the PVR, prostate size, or IPSS variables that
matched the desired fit and therefore, these variables were automatically excluded in this model. This model successfully classified 85% of
patients with 92% sensitivity and 65% specificity, 87% PPV, and 76% NPV for BOO (area under the curve for the diagnosis of BOO
0.85). The positive diagnostic likelihood ratio (LR) of this reclassification fit was 2.6. This indicates that BWT and Qmax would be of value
in the diagnosis of BOO independently.
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with BOO (AG number >40) than in the group of
patients without BOO (AG number 40), at 4 vs
2.8 mm, respectively.
To overcome the obstacle of the decrease in BWT
with the increase in the bladder filling volume, the
BWT was measured at fixed bladder filling volume of
250 mL, beyond which, the decrease in BWT is of no
statistical significance. Isikay et al. [15] measured the
BWT at a bladder filling of 150–200 mL and reported
a mean (SD) BWT of 4.14 (1.01) mm using a 7.5-MHz
linear probe. Manieri et al. [14] measured the BWT at
150-mL bladder filling in 174 patients using a 3.5-MHz
curvilinear probe, which is 100 mL less than the volume
at which BWT was measured in the present study. The
authors reported a mean BWT (SD) of 4.5 (1.1) mm
and a BWT threshold value of 5 mm was proposed to
be diagnostic for BOO, i.e. above this threshold likely
to have BOO. These two studies were done using US
transducers of different frequencies; moreover, the mea-
surements were done at different bladder volumes. This
might explain the diversity of the outcome of the mea-
sured BWT in these studies and the present study.
An interesting finding of our present study was that
the median BWT was higher in patients without DO
than in those with DO. Additionally, the median BWT
was higher in patients with BOO and DO than in the
patients with BOO but without DO within Group 1.
Although these were of no statistical significance, it
may indicate that the main cause of the increase in
BWT in these patients is the BOO and not DO.
Flowmetry and US assessment of PVR cannot distin-
guish BOO from detrusor underactivity but can still be
applied for initial evaluation and follow-up of patients
with LUTS. IPSS is representative of the patient percep-
tions but is subjective. And so, none of these abovemen-
tioned variables can yet replace conventional pressure-
flow studies in clinical practice. Therefore, an explora-
tory analysis was further performed to explore the
potential usefulness of BWT and other non-invasive
variables, i.e. Qmax, IPSS, PVR, and prostate size, in
clinical practice. Results of the RPA of these variables
showed the ability of the combination of BWT and Qmax
to correctly classify 85% of patients compared to the
conventional urodynamic diagnosis. The classification
model was aimed to combine all the variables of
BWT, Qmax, IPSS, PVR, and prostate size, but the
RPA program found no suitable cuts in the PVR, pros-
tate size, or IPSS variables that matched the desired fit
and therefore, these variables were automatically
excluded. The resultant model successfully classified
85% of patients. This indicates that BWT and Qmax
would be of value in the diagnosis of BOO
independently.
Conventional pressure-flow studies are still the stan-
dard diagnostic method for BOO in men with LUTS.
However, the algorithm developed in the present study
could be of value as a screening tool for BOO that les-
sens the need for invasive pressure-flow studies in many
patients with LUTS.
A limitation of the present study was that there was
no control group; however, it can be ascribed to the eth-
ical concerns about performing invasive urodynamic
testing in normal subjects.
Conclusion
BWT is significantly higher in patients with BOO and
significantly related to IPSS. It was possible to combine
BWT with Qmax to produce a new algorithm for diagno-
sis of BOO. This new diagnostic algorithm could be used
as a tool for screening of BOO in men with LUTS,
which would help in reducing unnecessary invasive
pressure-flow studies in these patients.
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